Robert J. Martin

FDA investigator

Appears on 29 documents from 2014 to 2023, most often at sites in Massachusetts. Most often cites control of microbiological contamination (21 CFR 211.113).

29
Documents on file
5.3
Observations per 483
2014
First seen
2023
Most recent

What they cite most

From 147 observations

Activity by year

2014: 1, 2015: 1, 2016: 1, 2017: 5, 2018: 3, 2019: 2, 2020: 3, 2021: 4, 2022: 5, 2023: 4

Where

Massachusetts 14 · Connecticut 5 · Maryland 5 · China 1 · Japan 1 · New Hampshire 1

Is Robert J. Martin coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

29 documents, newest first
FirmOpen
483 C&T Dream Co., LtdNov 10, 2023 · Cheonan, South Korea
483 Reliant Compounded Solutions Monroe, LLCAug 23, 2023 · Monroe, Connecticut
483 Vertex Pharmaceuticals IncorporatedMay 4, 2023 · Boston, Massachusetts
483 Azurity Pharmaceuticals, Inc.Mar 2, 2023 · Wilmington, Massachusetts
483 Fuji Yakuhin Co., Ltd.Nov 25, 2022 · Toyama-Shi, Japan
483 Pharmaceutics International, Inc.Nov 14, 2022 · Cockeysville, Maryland
483 Milbar Laboratories, Inc.Sep 27, 2022 · East Haven, Connecticut

About this profile

What does Robert J. Martin inspect?

Robert J. Martin appears on 29 documents on file covering 23 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Robert J. Martin is dated Nov 10, 2023.